| Name | CDK1/Cyc B-IN-1 |
|---|
| Description | CDK1/Cyc B-IN-1 (Compound 5) is a selective CDK1/Cyc B complex inhibitor with an IC50 of 97 nM. CDK1/Cyc B-IN-1 triggers apoptosis and G2/M cell cycle arrest. CDK1/Cyc B-IN-1 shows broad-spectrum cytotoxic action against cancer cell lines[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK1-Cyclin B:97 nM (IC50) |
| In Vitro | CDK1/Cyc B-IN-1 (Compound 5) shows cytotoxic activity with IC50 values of 5.33 ± 0.69 µM and 21.69 ± 1.04 µM against HCT-116 and WI-38, respectively[1]. |
| References |
| Molecular Formula | C14H12ClN3O2S2 |
|---|---|
| Molecular Weight | 353.85 |